Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1479, 2005-01, pp. : 9-10
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Expert Opinion on Investigational Drugs, Vol. 13, Iss. 5, 2004-05 ,pp. :
Access to resources
Recommend
Efalizumab's efficacy in psoriasis extends to the extremities
Inpharma, Vol. 1, Iss. 1576, 2007-01 ,pp. :
Efalizumab: durable benefits in plaque psoriasis
Inpharma, Vol. 1, Iss. 1385, 2003-01 ,pp. :
Tazarotene the clear winner for acne vulgaris
Inpharma, Vol. 1, Iss. 1427, 2004-01 ,pp. :
Telaprevir vs boceprevir: no clear winner
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 667, 2012-01 ,pp. :